Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.32 |
| ▸ | MAT2A | P31153 | 2/20 | 0.31 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.31 |
| ▸ | G6PD | P11413 | 2/20 | 0.31 |
| ▸ | DHFR | P00374 | 1/20 | 0.30 |
| ▸ | RORC | P51449 | 1/20 | 0.30 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22152517 | 1.00 | KDM4E (0.33) | KDM4EATML3MBTL1ALDH1A1LMNA | |
| SCHEMBL22153325 | 1.00 | KDM4E (0.33) | KDM4EATML3MBTL1ALDH1A1LMNA | |
| SCHEMBL22153229 | 1.00 | KDM4E (0.33) | KDM4EATML3MBTL1ALDH1A1LMNA | |
| SCHEMBL22152502 | 1.00 | KDM4E (0.33) | KDM4EATML3MBTL1ALDH1A1LMNA | |
| SCHEMBL22153936 | 1.00 | KDM4E (0.33) | KDM4EATML3MBTL1ALDH1A1LMNA | |
| SCHEMBL22153942 | 0.96 | KDM4E (0.33) | KDM4EATML3MBTL1ALDH1A1LMNA | |
| SCHEMBL22152777 | 0.96 | KDM4E (0.33) | KDM4EATML3MBTL1ALDH1A1LMNA | |
| SCHEMBL22153269 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1ALDH1A1LMNA | |
| SCHEMBL22152557 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1ALDH1A1LMNA | |
| SCHEMBL22152528 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200203625-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203625-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | KDM4E 3084/4885ATM 994/4885L3MBTL1 1470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.